More Than a Minor Headache: The Stem Cell Snake Oil Problem vs. Legitimate Research
Just two weeks ago, the headlines from Bloomberg News offered a glowing view of the prospects for stem cell therapies and the industry. The story in the online publication, which counts nearly 9 million readers monthly, said,
"Stem cell crusader sparks new hope....Regenerative medicine could be a $120 billion industry by 2030"
But only three days later, t…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.